MSD< Keytruda

Showing 1 posts of 1 posts found.


MSD’s Keytruda misses the mark at Phase 3 in advanced bladder cancer

June 11, 2020
Research and Development MSD< Keytruda, bladder cancer, pharma, trial failure

MSD has announced the disappointing findings that its anti-PD-1 immunotherapy Keytruda (pembrolizumab), when used either alone or combined with chemotherapy, …

Latest content